Recent findings indicate that pharmaceuticals are present in waterways worldwide, raising concerns about their impact on public health.
These contaminants are believed to be a key factor in the emergence of antibiotic-resistant superbugs, which are increasingly difficult to treat.
As this crisis unfolds, questions arise about potential solutions and the responsibility of pharmaceutical companies in preventing environmental contamination.